Ideas that have the potential to shape industries may end up stuck in the corporate basement. So how can companies embrace risky — but potentially revolutionary — ideas? Authors Safi Bahcall and Hugh Molotsi tackle this question in a main stage session at Innovation Leader’s 2019 Impact event. Bahcall also discusses learnings from his time as the CEO of Synta Pharmaceuticals, a company focused on developing new cancer treatments. Molotsi shares his experiences as a CEO of a startup and Vice President at Intuit. This session is moderated by Innovation Leader CEO Scott Kirsner.
